250 related articles for article (PubMed ID: 29486339)
1. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
Yoon HS; Hattori K; Sasayama D; Kunugi H
J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
[TBL] [Abstract][Full Text] [Related]
2. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
3. Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A
Psychiatry Res; 2008 Mar; 158(2):117-22. PubMed ID: 18096245
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity.
Ishiwata S; Hattori K; Sasayama D; Teraishi T; Miyakawa T; Yokota Y; Matsumura R; Nishikawa T; Kunugi H
J Affect Disord; 2018 Jan; 226():155-162. PubMed ID: 28985587
[TBL] [Abstract][Full Text] [Related]
5. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls.
Schmidt FM; Arendt E; Steinmetzer A; Bruegel M; Kratzsch J; Strauss M; Baum P; Hegerl U; Schönknecht P
Psychiatry Res; 2011 Dec; 190(2-3):240-3. PubMed ID: 21757240
[TBL] [Abstract][Full Text] [Related]
6. Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
Björkqvist M; Leavitt BR; Nielsen JE; Landwehrmeyer B; Ecker D; Mulder H; Brundin P; Petersén A
Mov Disord; 2007 Oct; 22(13):1952-4. PubMed ID: 17722045
[TBL] [Abstract][Full Text] [Related]
7. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia.
Sasayama D; Hattori K; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
Schizophr Res; 2012 Aug; 139(1-3):201-6. PubMed ID: 22742979
[TBL] [Abstract][Full Text] [Related]
8. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
[TBL] [Abstract][Full Text] [Related]
9. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
[TBL] [Abstract][Full Text] [Related]
10. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
Hung YY; Lin CC; Kang HY; Huang TL
Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
[TBL] [Abstract][Full Text] [Related]
11. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
Pech J; Forman J; Kessing LV; Knorr U
J Affect Disord; 2018 Nov; 240():6-16. PubMed ID: 30041075
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment.
Garakani A; Martinez JM; Yehuda R; Gorman JM
J Affect Disord; 2013 Apr; 146(2):262-5. PubMed ID: 22840611
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder.
Hidese S; Hattori K; Sasayama D; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Noda T; Yoshida S; Teraishi T; Hori H; Ota M; Kunugi H
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():12-18. PubMed ID: 28238731
[TBL] [Abstract][Full Text] [Related]
14. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
[TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder.
Ishiwata S; Hattori K; Sasayama D; Teraishi T; Miyakawa T; Yokota Y; Matsumura R; Yoshida F; Nishikawa T; Kunugi H
Psychiatry Res; 2017 Aug; 254():244-250. PubMed ID: 28477547
[TBL] [Abstract][Full Text] [Related]
16. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
Hou C; Jia F; Liu Y; Li L
Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
[TBL] [Abstract][Full Text] [Related]
17. Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness.
Constantinescu CS; Niepel G; Patterson M; Judd A; Braitch M; Fahey AJ; Harikrishnan S; Edwards LJ; Tench CR; Bennett GW; Ghatei M
J Neurol Sci; 2011 Aug; 307(1-2):127-31. PubMed ID: 21605873
[TBL] [Abstract][Full Text] [Related]
18. Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia.
Ishii T; Hattori K; Miyakawa T; Watanabe K; Hidese S; Sasayama D; Ota M; Teraishi T; Hori H; Yoshida S; Nunomura A; Nakagome K; Kunugi H
Biochem Biophys Res Commun; 2018 Mar; 497(2):683-688. PubMed ID: 29454970
[TBL] [Abstract][Full Text] [Related]
19. CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system.
Song MF; Dong JZ; Wang YW; He J; Ju X; Zhang L; Zhang YH; Shi JF; Lv YY
J Affect Disord; 2015 Jun; 178():25-31. PubMed ID: 25779937
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
Pae CU; Lee C; Paik IH
Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
